secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001104659-24-042513
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell Therapeutics removes Leerink Partners as ATM selling agent
--------------------------------------------------------------------------

- Amendment No. 1 to Distribution Agreement dated April 2, 2024 removes Leerink Partners as agent.
- Raymond James remains as the sole agent under the existing $100M ATM equity program.
- Original Distribution Agreement was entered August 9, 2021; no change to offering size or terms.
- Company's common stock trades on Nasdaq under ticker BCLI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924042513/0001104659-24-042513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924042513/tm2410454d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-042513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer